Romoli M, Mazzocchetti P, D’Alonzo R, Siliquini S, Rinaldi VE, Verrotti A, Calabresi P, Costa C (2019) Valproic acid and epilepsy: from molecular mechanisms to clinical evidences. Curr Neuropharmacol 17(10):926–946. https://doi.org/10.2174/1570159x17666181227165722

Article  CAS  PubMed  PubMed Central  Google Scholar 

Global, regional, and national burden of neurological disorders (2019) 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18 (5): 459–480. https://doi.org/10.1016/s1474-4422(18)30499-x

Allers K, Essue BM, Hackett ML, Muhunthan J, Anderson CS, Pickles K, Scheibe F, Jan S (2015) The economic impact of epilepsy: a systematic review. BMC Neurol 15(1):245. https://doi.org/10.1186/s12883-015-0494-y

Article  PubMed  PubMed Central  Google Scholar 

Devinsky O, Vezzani A, O'Brien TJ, Jette N, Scheffer IE, de Curtis M, Perucca P (2018) Epilepsy. Nature Reviews Disease Primers 4. https://doi.org/10.1038/nrdp.2018.24

Guo J, Ma J, Wang S, Li X, Ji H, Li Y, Peng F, Sun Y (2022) Valproic acid after neurosurgery induces elevated risk of liver injury: a prospective nested case-control study. Ann Pharmacother 56(8):888–897. https://doi.org/10.1177/10600280211055508

Article  CAS  PubMed  Google Scholar 

Yukawa E, To H, Ohdo S, Higuchi S, Aoyama T (1997) Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics. J Clin Pharmacol 37(12):1160–1167. https://doi.org/10.1002/j.1552-4604.1997.tb04301.x

Article  CAS  PubMed  Google Scholar 

Blanco-Serrano B, Otero M, Santos-Buelga D, García-Sánchez M, Serrano J, Domínguez-Gil A (1999) Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data. Biopharm Drug Dispos 20(5):233–240

Article  CAS  PubMed  Google Scholar 

Yukawa E, Nonaka T, Yukawa M, Higuchi S, Kuroda T, Goto Y (2003) Pharmacoepidemiologic investigation of a clonazepam-valproic acid interaction by mixed effect modeling using routine clinical pharmacokinetic data in Japanese patients. J Clin Pharm Ther 28(6):497–504

Article  CAS  PubMed  Google Scholar 

Vučićević K, Miljković B, Pokrajac M, Prostran M, Martinović Ž, Grabnar I (2009) The influence of drug–drug interaction and patients’ characteristics on valproic acid’s clearance in adults with epilepsy using nonlinear mixed effects modeling. Eur J Pharm Sci 38(5):512–518

Article  PubMed  Google Scholar 

Jankovic S, Milovanovic J, Jankovic S (2010) Factors influencing valproate pharmacokinetics in children and adults. Int J Clin Pharmacol Ther 48(11):767

Article  CAS  PubMed  Google Scholar 

Ibarra M, Vázquez M, Fagiolino P, Derendorf H (2013) Sex related differences on valproic acid pharmacokinetics after oral single dose. J Pharmacokinet Pharmacodyn 40:479–486

Article  CAS  PubMed  Google Scholar 

Lin W-w, Jiao Z, Wang C-l, Wang H-y, Ma C-l, Huang P-f, Guo X-z, Liu Y-w (2015) Population pharmacokinetics of valproic acid in adult Chinese epileptic patients and its application in an individualized dosage regimen. Ther Drug Monit 37(1):76–83

Article  PubMed  Google Scholar 

Methaneethorn J (2017) Population pharmacokinetics of valproic acid in patients with mania: implication for individualized dosing regimens. Clin Ther 39(6):1171–1181. https://doi.org/10.1016/j.clinthera.2017.04.005

Article  CAS  PubMed  Google Scholar 

Alqahtani S, Alandas N, Alsultan A (2019) Estimation of apparent clearance of valproic acid in adult Saudi patients. Int j clin pharm-net 41(4):1056–1061

Article  CAS  Google Scholar 

Teixeira-da-Silva P, Pérez-Blanco JS, Santos-Buelga D, Otero MJ, García MJ (2022) Population pharmacokinetics of valproic acid in pediatric and adult Caucasian patients. Pharmaceutics 14(4):811. https://doi.org/10.3390/pharmaceutics14040811

Zang YN, Guo W, Niu MX, Bao S, Wang Q, Wang Y, Dong F, Li AN, Ruan CJ (2022) Population pharmacokinetics of valproic acid in adult Chinese patients with bipolar disorder. Eur J Clin Pharmacol 78(3):405–418. https://doi.org/10.1007/s00228-021-03246-2

Article  CAS  PubMed  Google Scholar 

Methaneethorn J (2018) A systematic review of population pharmacokinetics of valproic acid. Br J Clin Pharmacol 84(5):816–834. https://doi.org/10.1111/bcp.13510

Article  PubMed  PubMed Central  Google Scholar 

El Desoky ES, Fuseau E, EL Din Amry S, Cosson V (2004) Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients. Eur J Clin Pharmacol 59:783–790

Article  PubMed  Google Scholar 

Ogusu N, Saruwatari J, Nakashima H, Noai M, Nishimura M, Deguchi M, Oniki K, Yasui-Furukori N, Kaneko S, Ishitsu T (2014) Impact of the superoxide dismutase 2 Val16Ala polymorphism on the relationship between valproic acid exposure and elevation of γ-glutamyltransferase in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysis. PLoS ONE 9(11):e111066

Article  PubMed  PubMed Central  Google Scholar 

Birnbaum AK, Ahn JE, Brundage RC, Hardie NA, Conway JM, Leppik IE (2007) Population pharmacokinetics of valproic acid concentrations in elderly nursing home residents. Ther Drug Monit 29(5):571–575

Article  CAS  PubMed  Google Scholar 

Zang Y-N, Guo W, Dong F, Li A-N, de Leon J, Ruan C-J (2022) Published population pharmacokinetic models of valproic acid in adult patients: a systematic review and external validation in a Chinese sample of inpatients with bipolar disorder. Expert Rev Clin Pharmacol 15(5):621–635. https://doi.org/10.1080/17512433.2022.2075849

Article  CAS  PubMed  Google Scholar 

TANIKAWA K, MATSUMOTO Y, MATSUMOTO M, FUKUOKA M, YAMAMOTO R, ENDO K, SAWACHI T, NAKAMURA T (1998) Population pharmacokinetic parameters of valproic acid; conventional and slow release formulation. Rinsho yakuri/Jpn J Clin Pharmacol Ther 29(3):489–94

Article  Google Scholar 

Jankovic S, Milovanovic J (2007) Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients. Methods Find Exp Clin Pharmacol 29(10):673–680

Article  CAS  PubMed  Google Scholar 

Methaneethorn J, Lohitnavy M (2020) External evaluation of a published population pharmacokinetic model of valproic acid in Thai manic patients. Eur J Hosp Pharm 27(3):168–172. https://doi.org/10.1136/ejhpharm-2018-001653

Article  PubMed  Google Scholar 

Yang L, Yang N, Yi B, Pei Q, Huang Z (2022) Population pharmacokinetic evaluation with external validation of tacrolimus in Chinese primary nephrotic syndrome patients. Pharm Res 39(8):1907–1920. https://doi.org/10.1007/s11095-022-03273-3

Article  CAS  PubMed  Google Scholar 

Bergstrand M, Hooker AC, Wallin JE, Karlsson MO (2011) Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J 13(2):143–151. https://doi.org/10.1208/s12248-011-9255-z

Article  PubMed  PubMed Central  Google Scholar 

Comets E, Brendel K, Mentré F (2008) Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R. Comput Methods Programs Biomed 90(2):154–166

Article  PubMed  Google Scholar 

Gumbert SD, Kork F, Jackson ML, Vanga N, Ghebremichael SJ, Wang CY, Eltzschig HK (2020) Perioperative acute kidney injury. Anesthesiology 132(1):180–204. https://doi.org/10.1097/ALN.0000000000002968

Article  PubMed  Google Scholar 

De Vlieger G, Meyfroidt G (2023) Kidney dysfunction after traumatic brain injury: pathophysiology and general management. Neurocrit Care 38(2):504–516. https://doi.org/10.1007/s12028-022-01630-z

Article  PubMed  Google Scholar 

Patsalos PN (2022) Valproic Acid. In: Patsalos PN (ed) Antiseizure Medication Interactions: A Clinical Guideed. Springer International Publishing, pp 261–267

Correa T, Rodriguez I, Romano S (2008) Population pharmacokinetics of valproate in Mexican children with epilepsy. Biopharm Drug Dispos 29(9):511–520. https://doi.org/10.1002/bdd.636

Article  CAS  PubMed  Google Scholar 

Ogusu N, Saruwatari J, Nakashima H, Noai M, Nishimura M, Deguchi M, Oniki K, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagaswa K (2014) Impact of the superoxide dismutase 2 Val16Ala polymorphism on the relationship between valproic acid exposure and elevation of γ-glutamyltransferase in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysis. PLoS ONE 9(11):e111066. https://doi.org/10.1371/journal.pone.0111066

Article  CAS